ipratropium + fenoterol


Boehringer Ingelheim


Concise Prescribing Info
Per mL Ipratropium Br 250 mcg, fenoterol HBr 500 mcg
Bronchodilator for the prevention & treatment of symptoms in chronic obstructive airway disorders w/ reversible airflow limitation eg, bronchial asthma & especially chronic bronchitis w/ or w/o emphysema. Concomitant anti-inflammatory therapy should be considered for patients w/ bronchial asthma & steroid responsive COPD.
Dosage/Direction for Use
Adult (including elderly) & adolescent >12 yr Acute bronchospasm episodes 1-2.5 mL (20-50 drops). Severe cases 4 mL (80 drops). Acute asthma episodes Childn 6-12 yr 0.5-2 mL (10-40 drops), <6 yr (<22 kg) 0.1 mL (2 drops)/kg. Max: 0.5 mL (10 drops).
Hypersensitivity to fenoterol HBr or atropine-like substances. Patients w/ hypertrophic obstructive cardiomyopathy & tachyarrhythmia.
Special Precautions
Hypersensitivity. Immediately discontinue if paradoxical bronchospasm occurs. Patients predisposed to narrow-angle glaucoma; insufficiently controlled DM, recent MI, severe organic heart or vascular disorders, hyperthyroidism, phaeochromocytoma, pre-existing urinary outflow tract obstruction (eg, prostatic hyperplasia or bladder-neck obstruction); severe heart disease (eg, ischaemic heart disease, arrhythmia or severe heart failure). Hypokalaemia; cystic fibrosis; acute, rapidly worsening dyspnoea; doping. Prolonged use. Concomitant use w/ other sympathomimetic bronchodilators. May cause wheezing & breathing difficulties due to benzalkonium chloride content; increased risk of adverse events for asthma patients. Avoid contact w/ eyes. May affect ability to drive & use machines. Pregnancy & lactation.
Adverse Reactions
Cough, dry mouth, headache, tremor, pharyngitis, nausea, dizziness, dysphonia, tachycardia, palpitations, vomiting, increased systolic BP & nervousness.
Drug Interactions
Chronic co-administration w/ other anticholinergics is not recommended. May enhance bronchodilatory effect w/ other β-adrenergics, anticholinergics & xanthine derivatives (eg, theophylline). Potentially serious reduction in bronchodilatation w/ β-blockers. Induced hypokalaemia w/ xanthine derivatives, corticosteroids & diuretics. May increase susceptibility to arrhythmias w/ digoxin. May enhance actions by MAOIs, TCAs. May increase susceptibility on CV effects w/ halogenated hydrocarbon anaesth inhalation eg, halothane, trichloroethylene & enflurane.
ATC Classification
R03AL01 - fenoterol and ipratropium bromide ; Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
Berodual inhalation soln
20 mL x 1's ($19.65/bottle)
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in